Sitewide Sale! 15% OFF! Use Code EPX15 *
Shipping is $36.95 + a $6 surcharge for ice. Your order will ship via Express 1-2 day mail and will be packed in an insulated box with ice packs. Items that are required to ship this method will be listed in the item description. Orders placed after 2:00 PM EST (11:pp AM PST) may not end up being able to ship out the same day.
Restrictions: All foreign orders are ineligible. Free shipping is ineligible.
Note: Vaccine orders are only shipped out on Mon-Wed. due to Express service only being able to deliver during weekdays. We cannot be responsible for vaccine or other refrigerated orders that are delayed because no one is present at the time it is delivered.
NASALGEN® IP is for the vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis and parainfluenza3 virus. Nasalgen IP vaccine is safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.
Aseptically rehydrate Nasalgen® IP vaccine with the enclosed diluent. Administer 2 mL into one nostril or 1 mL into each nostril for a 2 mL dose, using a separate disposable cannula for each animal.
Nasalgen® IP vaccine is safe for use in pregnant cows or in calves nursing pregnant cows. Calves vaccinated under 5 months of age should be revaccinated at 5 months of age or weaning.
FOR INTRANASAL USE ONLY
FOR ANIMAL USE ONLY
Store at 2°-7°C (35°-45°F). Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes, needles or cannulas. Burn container and all unused contents. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use, treat with epinephrine. Contains gentamicin as a preservative.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy. This level of performance may be affected by conditions of use such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions